AbbVie Inc.

ABBV
HealthcareDividend Aristocrat
$211.93
3.18%Overvalued

AbbVie Inc. (ABBV) is a Healthcare company that currently yields 3.18% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $101.50 and the overvaluation threshold at $222.05. AbbVie Inc. holds a quality score of 37/100 (Risky), reflecting 9 consecutive years of dividend growth. The 5-year dividend CAGR stands at 6.8%.

ABBV Dividend Yield History — Weiss Valuation

Underval. $101.50Overval. $222.05
Price
Undervalued band
Overvalued band

Why Now?

AbbVie Inc. is trading near its historical overvaluation band.

Current yield 3.2% vs historical max 6.6% (48% of maximum).

9 years of uninterrupted dividends.

Elevated payout ratio of 326%.

ABBV Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$340

Year 10 Income

$911

Yield on Cost

9.67%

Total Income

$5,747

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

ABBV Dividend Quality Score

Quality Score

37/ 100

Risky

Payout Ratio0/25
Dividend Streak12/25
Growth (CAGR 5Y)15/20
Yield vs History0/15
FCF Coverage10/15

Key Metrics

Current Price$211.93
Annual Dividend$6.74
Current Yield3.18%
Yield — Max (10Y)6.64%
Yield — Min (10Y)3.04%
Undervalued Below$101.50
Overvalued Above$222.05
Payout Ratio325.98%
CAGR Dividend 5Y6.8%
CAGR Dividend 10Y—
Years No Cut9y
9
consecutive years of dividend growth

In-depth analysis

→ ABBV Dividend Analysis Article

Collections

→ Dividend Aristocrats→ Full Watchlist